In addition, the PYGB inhibitor has been recognized as a kind of prospective drug for treating ischemic brain injury [14,15,19,20], and as a potential novel anti-ischemic stroke drug has a favorable prospect for research and development. The gene discussed is PYGB; the disease is ischemic stroke.